Health
Sortilin may hold the key to developing more effective treatment for pancreatic cancer – News-Medical.Net
Pancreatic cancer has an extremely poor prognosis; it is the third most common cause of cancer deaths in the United States.
Reviewed by Emily Henderson, B.Sc.Aug 20 2020
Pancreatic cancer has an extremely poor prognosis; it is the third most common cause of cancer deaths in the United States. In a novel study published in TheAmerican Journal of Pathology, published by Elsevier, scientists report the discovery of an increased level of the neuroprotein sortilin in pancreatic cancer cells that may open up the way to developing more effective treatment.
There is currently no good therapy for pancreatic cancer. What we …
-
General22 hours agoAustralian economy still vulnerable to US bond turmoil
-
Business20 hours ago2 ASX 200 shares that could be top buys for growth
-
General7 hours agoDemocratic senators want an investigation into potential market manipulation from Trump’s inner circle
-
Business18 hours agoWhat I’d buy before the ASX rebounds: 3 high-conviction share picks